Literature DB >> 21987284

High resolution SPECT imaging for visualization of intratumoral heterogeneity using a SPECT/CT scanner dedicated for small animal imaging.

Izumi O Umeda1, Kotaro Tani, Keisuke Tsuda, Masamitsu Kobayashi, Mayumi Ogata, Sadaaki Kimura, Mitsuyoshi Yoshimoto, Shuji Kojima, Kunikazu Moribe, Keiji Yamamoto, Noriyuki Moriyama, Hirofumi Fujii.   

Abstract

OBJECTIVES: Tumor interiors are never homogeneous and in vivo visualization of intratumoral heterogeneity would be an innovation that contributes to improved cancer therapy. But, conventional nuclear medicine tests have failed to visualize heterogeneity in vivo because of limited spatial resolution. Recently developed single photon emission computed tomographic (SPECT) scanners dedicated for small animal imaging are of interest due to their excellent spatial resolution of <1 mm, but few studies have focused on the evaluation of intratumoral heterogeneity. We investigated the optimal conditions related to high resolution imaging of heterogeneous tumor interiors using a small animal SPECT scanner.
METHODS: The conditions related to SPECT/CT visualization of heterogeneous tumor interiors were investigated using phantoms with (111)In and simulations of actual small animal imaging. The optimal conditions obtained were validated by in vivo imaging of sarcoma 180-bearing mice.
RESULTS: Larger number of counts must be obtained within limited acquisition time to visualize tumor heterogeneity in vivo in animal imaging, compared to cases that simply detect tumors. At an acquisition time of 30 min, better image quality was obtained with pinhole apertures diameter of 1.4 mm than of 1.0 mm. The obtained best spatial resolution was 1.3 mm, it was acceptable for our purpose, though a little worse than the best possible performance of the scanner (1.0 mm). Additionally, the reconstruction parameters, such as noise suppression, voxel size, and iteration/subset number, needed to be optimized under the limited conditions and were different from those found under the ideal condition. The minimal radioactivity concentration for visualization of heterogeneous tumor interiors was estimated to be as high as 0.2-0.5 MBq/mL. Liposomes containing (111)In met this requirement and were administered to tumor-bearing mice. SPECT imaging successfully showed heterogeneous (111)In distribution within the tumors in vivo with good spatial resolution. A threshold of 0.2 MBq/g for clear visualization of tumor heterogeneity was validated. Autoradiograms obtained ex vivo of excised tumors confirmed that the in vivo SPECT images accurately depicted the heterogeneous intratumoral accumulation of liposomes.
CONCLUSION: Intratumoral heterogeneity was successfully visualized under the optimized conditions using a SPECT/CT scanner.

Entities:  

Mesh:

Year:  2011        PMID: 21987284     DOI: 10.1007/s12149-011-0542-7

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  5 in total

1.  In vivo visualization of heterogeneous intratumoral distribution of hypoxia-inducible factor-1α activity by the fusion of high-resolution SPECT and morphological imaging tests.

Authors:  Hirofumi Fujii; Masayuki Yamaguchi; Kazumasa Inoue; Yasuko Mutou; Masashi Ueda; Hideo Saji; Shinae Kizaka-Kondoh; Noriyuki Moriyama; Izumi O Umeda
Journal:  J Biomed Biotechnol       Date:  2012-06-12

2.  Effects of attenuation map accuracy on attenuation-corrected micro-SPECT images.

Authors:  Chao Wu; Hugo A Gratama van Andel; Peter Laverman; Otto C Boerman; Freek J Beekman
Journal:  EJNMMI Res       Date:  2013-01-31       Impact factor: 3.138

Review 3.  The role of preclinical SPECT in oncological and neurological research in combination with either CT or MRI.

Authors:  Monique R Bernsen; Pieter E B Vaissier; Roel Van Holen; Jan Booij; Freek J Beekman; Marion de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05       Impact factor: 9.236

4.  Radiolabeled liposome imaging determines an indication for liposomal anticancer agent in ovarian cancer mouse xenograft models.

Authors:  Ken Ito; Shusei Hamamichi; Makoto Asano; Yusaku Hori; Junji Matsui; Masao Iwata; Yasuhiro Funahashi; Izumi O Umeda; Hirofumi Fujii
Journal:  Cancer Sci       Date:  2015-11-30       Impact factor: 6.716

5.  Antitumor effects of eribulin depend on modulation of the tumor microenvironment by vascular remodeling in mouse models.

Authors:  Ken Ito; Shusei Hamamichi; Takanori Abe; Tsuyoshi Akagi; Hiroshi Shirota; Satoshi Kawano; Makoto Asano; Osamu Asano; Akira Yokoi; Junji Matsui; Izumi O Umeda; Hirofumi Fujii
Journal:  Cancer Sci       Date:  2017-09-22       Impact factor: 6.716

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.